CBD Case Studies

BOISE, Idaho — The Food and Drug Administration is one step closer to approving a prescription CBD oil. Participants in an Idaho case study may have played a role in the decision-making process. A panel of federal advisers unanimously voted last week to recommend the approval of the Epidiolex, the first prescription cannabidiol medicine, to […]

by

This article originally appeared on the Conversation.  In the 1930s, Harry J. Anslinger, the first head of the Federal Bureau of Narcotics, embarked on a fierce anti-marijuana campaign. Highlighted by the 1936 anti-marijuana film Reefer Madness—where marijuana is depicted as a dangerous narcotic that makes good kids become sex-crazed killers—his propaganda efforts also maliciously linked marijuana use […]

by

As more states legalize marijuana, a by-product of the cannabis plant called CBD oil has also enjoyed an increasingly starry profile as a beauty and wellness ingredient. And it’s only going to become more mainstream. Yesterday, an FDA advisory group unanimously recommended that Epidiolex, a CBD-based oral medication for treating two serious types of childhood […]

by

This article originally appeared on the Conversation.  In the 1930s, Harry J. Anslinger, the first head of the Federal Bureau of Narcotics, embarked on a fierce anti-marijuana campaign. Highlighted by the 1936 anti-marijuana film Reefer Madness—where marijuana is depicted as a dangerous narcotic that makes good kids become sex-crazed killers—his propaganda efforts also maliciously linked marijuana use […]

by

This article originally appeared on the Conversation.  In the 1930s, Harry J. Anslinger, the first head of the Federal Bureau of Narcotics, embarked on a fierce anti-marijuana campaign. Highlighted by the 1936 anti-marijuana film Reefer Madness—where marijuana is depicted as a dangerous narcotic that makes good kids become sex-crazed killers—his propaganda efforts also maliciously linked marijuana use […]

by

Posted in: Medical Science News | Medical Research News | Medical Condition News Tags: Adolescents, Anxiety, Brain, Cannabis, Compound, Drug Abuse, Education, Epilepsy, Neuroscience, Placebo, Psychology, Research, Schizophrenia … read more at: https://www.news-medical.net/news/20170906/Cannabidiol-appears-to-protect-against-long-term-negative-psychiatric-effects-of-THC.aspx

by

The most interesting thing about owning Pure CBD Exchange is seeing the variety of our clientele. This was also the case in my time operating dispensaries in Aspen and Denver, but diversity and accessibility are on another level in the CBD market. Our site serves customers across the country and throughout the world. We interact […]

by

When Peru’s medical marijuana law was signed by President Pedro Pablo Kuczynski on Nov. 16, it was hailed as a victory by advocates — especially the mothers of the Buscando Esperanza (Seeking Hope) collective, who were producing cannabis for their ailing children. The police raid on their operation in a Lima apartment just over a year ago […]

by

There is perhaps no cannabinoid more misunderstood than cannabinol, or CBN as it is better known. Once thought to be the primary source of the psychoactive effects associated with marijuana, CBN has an ancient tie to cannabis’ first concentrate, hashish, and is now being explored and isolated to provide relief for conditions like insomnia. The […]

The popularity of small, portable vaporizer “pens” has become a national phenomenon, with digital concentrate vaping rapidly replacing joint smoking as the entry point for new cannabis users. But are these devices (and the concentrates inside them) safe? Jahan Marcu, Ph.D., is the chief science advisor at Americans for Safe Access. In 2015 he wrote […]